Posted by Michael Wonder on 01 Jun 2020
Expanded PBS medicines listings to provide new treatment options for over 170,000 asthmatics, and new hope for blood cancer patients
1 June 2020 - Australians with asthma and multiple myeloma will have broader access to life changing medicines as a result of expanded medicines listings on Pharmaceutical Benefits Scheme from 1 June 2020.
The listing of Symbicort (containing budesonide and formoterol) will now be available at PBS prices for adolescent and adult patients with mild asthma.
Patients with more severe forms of asthma will also benefit from the listing of a new pre-filled self-administered auto-injector pen, from 1 June.
